2014
DOI: 10.1186/1472-6890-14-19
|View full text |Cite
|
Sign up to set email alerts
|

A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon

Abstract: BackgroundEDTA-dependent pseudothrombocytopenia (EDTA-PTCP) is a common laboratory phenomenon with a prevalence ranging from 0.1-2% in hospitalized patients to 15-17% in outpatients evaluated for isolated thrombocytopenia. Despite its harmlessness, EDTA-PTCP frequently leads to time-consuming, costly and even invasive diagnostic investigations. EDTA-PTCP is often overlooked because blood smears are not evaluated visually in routine practice and histograms as well as warning flags of hematology analyzers are no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
54
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 45 publications
(59 citation statements)
references
References 19 publications
1
54
0
4
Order By: Relevance
“…However, some other anticoagulants such as heparin, oxalate, hirudin, citrate, or abciximab may also cause pseudothrombocytopenia, although their actual incidence is still unclear. [5] The underlying mechanism of platelet clumping in pseudothrombocytopenia includes an immunological process which was first described by Shreiner and Bell in 1973. [6] The authors proved that EDTA caused a new type of platelet agglutinin, which was active at 37 °C, as well as at room temperature.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…However, some other anticoagulants such as heparin, oxalate, hirudin, citrate, or abciximab may also cause pseudothrombocytopenia, although their actual incidence is still unclear. [5] The underlying mechanism of platelet clumping in pseudothrombocytopenia includes an immunological process which was first described by Shreiner and Bell in 1973. [6] The authors proved that EDTA caused a new type of platelet agglutinin, which was active at 37 °C, as well as at room temperature.…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence of EDTAdependent pseudothrombocytopenia is reported to be between 0.1% and 2% among hospitalized patients and up to 17% in patients with isolated thrombocytopenia. [3,5] The EDTA is an anticoagulant, which is frequently used for hematological tests, and may induce platelet clumping. However, some other anticoagulants such as heparin, oxalate, hirudin, citrate, or abciximab may also cause pseudothrombocytopenia, although their actual incidence is still unclear.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations